Membranous nephropathy: mechanistic insights and therapeutic perspectives

MR Hua, YL Zhao, JZ Yang, L Zou, YY Zhao… - International …, 2023 - Elsevier
Membranous nephropathy (MN) is one of the most common causes of non-diabetic
nephrotic syndrome in adults. About 80% of cases are renal limited (primary MN) and 20 …

B cell dysregulation and depletion therapy in primary membranous nephropathy: Prospects and potential challenges

Y Wu, H Jiang, Y Hu, H Dai, Q Zhao, Y Zheng… - International …, 2024 - Elsevier
B cells are crucial to the humoral immune response, originating in the bone marrow and
maturing in the spleen and lymph nodes. They primarily function to protect against a wide …

[HTML][HTML] Activation of the IL-6/STAT3 pathway contributes to the pathogenesis of membranous nephropathy and is a target for Mahuang Fuzi and Shenzhuo Decoction …

Q Zhao, H Dai, H Jiang, N Zhang, F Hou… - Biomedicine & …, 2024 - Elsevier
Background Primary membranous nephropathy (PMN) is an autoimmune glomerular
disease. IL-6 is a potential therapeutic target for PMN. Previous clinical studies have …

Prognostic and therapeutic monitoring value of plasma and urinary cytokine profile in primary membranous nephropathy: the STARMEN trial cohort

JE Rojas-Rivera, T Hasegawa… - Clinical Kidney …, 2024 - academic.oup.com
Background Primary membranous nephropathy (PMN) is usually caused by anti-
phospholipase A2 receptor (PLA2R) autoantibodies. There are different therapeutic options …

The value of peripheral blood cell ratios in primary membranous nephropathy: a single Center Retrospective Study

AH Zhang, GX Dai, QD Zhang, HD Huang… - Journal of Inflammation …, 2023 - Taylor & Francis
Background Primary membranous nephropathy (PMN) is a common cause of nephrotic
syndrome in adults. Forty percent of the patients continue to progress and eventually …

A nomogram prediction model for treatment failure in primary membranous nephropathy

C Geng, L Huang, Q Li, G Li, Y Li, P Zhang, Y Feng - Renal Failure, 2023 - Taylor & Francis
Background Primary membranous nephropathy (PMN) has a heterogeneous natural course.
Immunosuppressive therapy is recommended for PMN patients at moderate or high risk of …

[HTML][HTML] Detailed Pathophysiology of Minimal Change Disease: Insights into Podocyte Dysfunction, Immune Dysregulation, and Genetic Susceptibility

M Roman, M Nowicki - International Journal of Molecular Sciences, 2024 - mdpi.com
Minimal Change Disease (MCD) is a predominant cause of idiopathic nephrotic syndrome in
the pediatric population, yet presents significant clinical challenges due to its frequent …

[HTML][HTML] IL-12 family cytokines and autoimmune diseases: A potential therapeutic target?

X Cui, W Liu, H Jiang, Q Zhao, Y Hu, X Tang… - Journal of Translational …, 2024 - Elsevier
In recent years, the discovery of IL-12 family cytokines, which includes IL-12, IL-23, IL-27, IL-
35, and IL-39, whose biological functions directly or indirectly affect various autoimmune …

[HTML][HTML] Experimental models for elderly patients with membranous nephropathy: Application and advancements

X Tang, H Dai, Y Hu, W Liu, Q Zhao, H Jiang… - Experimental …, 2024 - Elsevier
Membranous nephropathy (MN) occurs predominantly in middle-aged and elderly
individuals and ranks among the most prevalent etiologies of elderly nephrotic syndrome. As …

Modified Huangqi Chifeng decoction alleviates podocyte injury on rat with experimental membranous nephropathy

M Chang, X Shi, B Yang, P Li, Y Zhang, Q Zhang… - Renal …, 2025 - Taylor & Francis
Objective This study aims to investigate the therapeutic effects of modified Huangqi Chifeng
decoction (MHCD) on proteinuria in membranous nephropathy (MN) and its potential …